| 1027 | -0.8483 | 7.936 | -6.145 | 2.569e-09 | 2.73e-08 | 10.36 | 1027 | CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | ENSG00000111276 | 600778, 610755 |
| 10395 | 1.048 | 7.589 | 5.057 | 7.472e-07 | 5.625e-06 | 4.86 | 10395 | DLC1 | deleted in liver cancer 1 | ENSG00000164741 | 604258 |
| 10458 | 1.482 | 5.618 | 13.44 | 1.695e-32 | 1.614e-30 | 63.07 | 10458 | BAIAP2 | BAI1-associated protein 2 | ENSG00000175866 | 605475 |
| 10524 | -1.108 | 7.19 | -13.04 | 4.959e-31 | 4.169e-29 | 59.72 | 10524 | KAT5 | K(lysine) acetyltransferase 5 | ENSG00000172977 | 601409 |
| 10787 | -0.3254 | 10.5 | -5.476 | 9.285e-08 | 7.98e-07 | 6.876 | 10787 | NCKAP1 | NCK-associated protein 1 | ENSG00000061676 | 604891 |
| 11214 | 1.277 | 7.767 | 14.17 | 3.753e-35 | 4.697e-33 | 69.13 | 11214 | AKAP13 | A kinase (PRKA) anchor protein 13 | ENSG00000170776 | 604686 |
| 11221 | 2.424 | 6.059 | 11.27 | 9.433e-25 | 4.471e-23 | 45.39 | 11221 | DUSP10 | dual specificity phosphatase 10 | ENSG00000143507 | 608867 |
| 1124 | 0.7539 | 5.364 | 8.918 | 4.976e-17 | 1.172e-15 | 27.8 | 1124 | CHN2 | chimerin (chimaerin) 2 | ENSG00000106069 | 602857 |
| 1386 | -0.5172 | 7.487 | -3.881 | 0.0001283 | 0.0006793 | -0.05683 | 1386 | ATF2 | activating transcription factor 2 | ENSG00000115966 | 123811 |
| 1466 | 0.7358 | 8.948 | 9.072 | 1.657e-17 | 4.033e-16 | 28.89 | 1466 | CSRP2 | cysteine and glycine-rich protein 2 | ENSG00000175183 | 601871 |
| 1647 | 0.6207 | 10.15 | 5.466 | 9.763e-08 | 8.358e-07 | 6.827 | 1647 | GADD45A | growth arrest and DNA-damage-inducible, alpha | ENSG00000116717 | 126335 |
| 1649 | 0.3815 | 7.829 | 4.465 | 1.141e-05 | 7.207e-05 | 2.242 | 1649 | DDIT3 | DNA-damage-inducible transcript 3 | ENSG00000175197 | 126337, 613488 |
| 1843 | 1.559 | 8.384 | 6.057 | 4.202e-09 | 4.331e-08 | 9.884 | 1843 | DUSP1 | dual specificity phosphatase 1 | ENSG00000120129 | 600714 |
| 1847 | 1.989 | 8.872 | 10.12 | 7.234e-21 | 2.412e-19 | 36.53 | 1847 | DUSP5 | dual specificity phosphatase 5 | ENSG00000138166 | 603069 |
| 1894 | -0.4168 | 10.08 | -6.122 | 2.929e-09 | 3.097e-08 | 10.24 | 1894 | ECT2 | epithelial cell transforming sequence 2 oncogene | ENSG00000114346 | 600586 |
| 2033 | -0.7882 | 6.866 | -7.239 | 3.891e-12 | 5.622e-11 | 16.71 | 2033 | EP300 | E1A binding protein p300 | ENSG00000100393 | 114500, 180849, 602700, 613684 |
| 2059 | 1.082 | 9.388 | 10.76 | 5.071e-23 | 2.047e-21 | 41.44 | 2059 | EPS8 | epidermal growth factor receptor pathway substrate 8 | ENSG00000151491 | 600206 |
| 23365 | 0.5819 | 6.248 | 4.909 | 1.516e-06 | 1.09e-05 | 4.178 | 23365 | ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | ENSG00000196914 | 601626, 604763 |
| 23370 | 0.4501 | 10.89 | 4.325 | 2.084e-05 | 0.0001261 | 1.667 | 23370 | ARHGEF18 | Rho/Rac guanine nucleotide exchange factor (GEF) 18 | ENSG00000104880 | NA |
| 23396 | 0.5604 | 7.272 | 5.25 | 2.904e-07 | 2.334e-06 | 5.772 | 23396 | PIP5K1C | phosphatidylinositol-4-phosphate 5-kinase, type I, gamma | ENSG00000186111 | 606102, 611369 |
| 2353 | 0.471 | 4.873 | 5.578 | 5.479e-08 | 4.845e-07 | 7.387 | 2353 | FOS | FBJ murine osteosarcoma viral oncogene homolog | ENSG00000170345 | 164810 |
| 26999 | 0.6302 | 5.332 | 5.442 | 1.107e-07 | 9.4e-07 | 6.706 | 26999 | CYFIP2 | cytoplasmic FMR1 interacting protein 2 | ENSG00000055163 | 606323 |
| 29127 | -0.5662 | 10.71 | -11.64 | 4.944e-26 | 2.629e-24 | 48.31 | 29127 | RACGAP1 | Rac GTPase activating protein 1 | ENSG00000161800 | 604980 |
| 3491 | 1.055 | 10.54 | 6.101 | 3.277e-09 | 3.441e-08 | 10.13 | 3491 | CYR61 | cysteine-rich, angiogenic inducer, 61 | ENSG00000142871 | 602369 |
| 392 | -0.4401 | 9.846 | -6.167 | 2.274e-09 | 2.425e-08 | 10.48 | 392 | ARHGAP1 | Rho GTPase activating protein 1 | ENSG00000175220 | 602732 |
| 395 | 0.3209 | 4.602 | 4.047 | 6.62e-05 | 0.000367 | 0.5686 | 395 | ARHGAP6 | Rho GTPase activating protein 6 | ENSG00000047648 | 300118 |
| 4650 | 0.5482 | 6.463 | 4.312 | 2.207e-05 | 0.000133 | 1.612 | 4650 | MYO9B | myosin IXB | ENSG00000099331 | 602129, 609753 |
| 4763 | -0.4082 | 7.425 | -4.762 | 3.002e-06 | 2.071e-05 | 3.521 | 4763 | NF1 | neurofibromin 1 | ENSG00000196712 | 162200, 162210, 193520, 601321, 607785, 613113 |
| 50650 | 1.149 | 7.935 | 10.96 | 1.051e-23 | 4.51e-22 | 43 | 50650 | ARHGEF3 | Rho guanine nucleotide exchange factor (GEF) 3 | ENSG00000163947 | 612115 |
| 5156 | 1.224 | 6.592 | 3.912 | 0.0001134 | 0.0006062 | 0.05958 | 5156 | PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | ENSG00000134853 | 173490, 606764, 607685 |
| 5268 | 0.7504 | 9.85 | 5.951 | 7.512e-09 | 7.471e-08 | 9.318 | 5268 | SERPINB5 | serpin peptidase inhibitor, clade B (ovalbumin), member 5 | ENSG00000206075 | 154790 |
| 5328 | -1.162 | 11.72 | -8.94 | 4.26e-17 | 1.011e-15 | 27.96 | 5328 | PLAU | plasminogen activator, urokinase | ENSG00000122861 | 104300, 191840, 601709 |
| 55114 | 0.5787 | 8.628 | 6.702 | 1.032e-10 | 1.278e-09 | 13.5 | 55114 | ARHGAP17 | Rho GTPase activating protein 17 | ENSG00000140750 | 608293 |
| 55160 | -0.3413 | 5.347 | -4.176 | 3.907e-05 | 0.0002247 | 1.069 | 55160 | ARHGEF10L | Rho guanine nucleotide exchange factor (GEF) 10-like | ENSG00000074964 | 612494 |
| 55200 | 0.4606 | 5.049 | 5.583 | 5.351e-08 | 4.74e-07 | 7.41 | 55200 | PLEKHG6 | pleckstrin homology domain containing, family G (with RhoGef domain) member 6 | ENSG00000008323 | 611743 |
| 5578 | 0.9039 | 7.313 | 9.863 | 4.949e-20 | 1.508e-18 | 34.63 | 5578 | PRKCA | protein kinase C, alpha | ENSG00000154229 | 176960 |
| 5606 | 1.656 | 9.058 | 12.58 | 2.254e-29 | 1.63e-27 | 55.93 | 5606 | MAP2K3 | mitogen-activated protein kinase kinase 3 | ENSG00000034152 | 602315 |
| 5608 | 0.6606 | 7.955 | 5.423 | 1.215e-07 | 1.027e-06 | 6.616 | 5608 | MAP2K6 | mitogen-activated protein kinase kinase 6 | ENSG00000108984 | 601254 |
| 57591 | 0.5278 | 6.034 | 4.795 | 2.573e-06 | 1.796e-05 | 3.669 | 57591 | MKL1 | megakaryoblastic leukemia (translocation) 1 | ENSG00000196588 | 606078 |
| 595 | -0.7809 | 10.02 | -5.764 | 2.053e-08 | 1.921e-07 | 8.34 | 595 | CCND1 | cyclin D1 | ENSG00000110092 | 114500, 151400, 168461, 193300, 254500 |
| 596 | 0.3663 | 4.863 | 4.324 | 2.096e-05 | 0.0001267 | 1.662 | 596 | BCL2 | B-cell CLL/lymphoma 2 | ENSG00000171791 | 151430 |
| 64411 | -0.624 | 6.405 | -6.436 | 4.917e-10 | 5.643e-09 | 11.98 | 64411 | ARAP3 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 | ENSG00000120318 | 606647 |
| 6456 | 0.8933 | 5.034 | 4.598 | 6.321e-06 | 4.155e-05 | 2.807 | 6456 | SH3GL2 | SH3-domain GRB2-like 2 | ENSG00000107295 | 604465 |
| 6548 | 0.9585 | 8.519 | 8.857 | 7.663e-17 | 1.776e-15 | 27.38 | 6548 | SLC9A1 | solute carrier family 9 (sodium/hydrogen exchanger), member 1 | ENSG00000090020 | 107310 |
| 6654 | -0.9652 | 8.464 | -9.073 | 1.644e-17 | 4.011e-16 | 28.9 | 6654 | SOS1 | son of sevenless homolog 1 (Drosophila) | ENSG00000115904 | 135300, 163955, 182530, 610733 |
| 672 | -0.4574 | 7.28 | -4.677 | 4.437e-06 | 2.984e-05 | 3.146 | 672 | BRCA1 | breast cancer 1, early onset | ENSG00000012048 | 113705, 114480, 604370, 614320 |
| 7074 | 1.194 | 8.01 | 10.43 | 6.668e-22 | 2.464e-20 | 38.89 | 7074 | TIAM1 | T-cell lymphoma invasion and metastasis 1 | ENSG00000156299 | 600687 |
| 7204 | -0.5247 | 7.799 | -4.753 | 3.126e-06 | 2.151e-05 | 3.482 | 7204 | TRIO | triple functional domain (PTPRF interacting) | ENSG00000038382 | 601893 |
| 7414 | 0.4394 | 12.74 | 12.08 | 1.407e-27 | 8.564e-26 | 51.84 | 7414 | VCL | vinculin | ENSG00000035403 | 193065, 611407, 613255 |
| 7430 | 0.6066 | 10.14 | 9.032 | 2.208e-17 | 5.313e-16 | 28.61 | 7430 | EZR | ezrin | ENSG00000092820 | 123900 |
| 7984 | -0.4413 | 7.107 | -5.19 | 3.914e-07 | 3.09e-06 | 5.484 | 7984 | ARHGEF5 | Rho guanine nucleotide exchange factor (GEF) 5 | ENSG00000050327 | 600888 |
| 8452 | -0.1968 | 10.76 | -4.796 | 2.566e-06 | 1.793e-05 | 3.672 | 8452 | CUL3 | cullin 3 | ENSG00000036257 | 603136, 614496 |
| 890 | -0.813 | 8.733 | -9.999 | 1.772e-20 | 5.647e-19 | 35.65 | 890 | CCNA2 | cyclin A2 | ENSG00000145386 | 123835 |
| 8936 | 0.57 | 8.383 | 7.135 | 7.464e-12 | 1.044e-10 | 16.08 | 8936 | WASF1 | WAS protein family, member 1 | ENSG00000112290 | 605035 |
| 9639 | 0.5456 | 7.816 | 5.432 | 1.163e-07 | 9.857e-07 | 6.658 | 9639 | ARHGEF10 | Rho guanine nucleotide exchange factor (GEF) 10 | ENSG00000104728 | 608136, 608236 |
| 9826 | -0.379 | 6.876 | -3.994 | 8.208e-05 | 0.0004484 | 0.365 | 9826 | ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | ENSG00000132694 | 605708 |